Morphine or Ketamine for Analgesia
Recruiting
Phase 3
Interventional Study
Abdominal Pain
Isolated Extremity Fracture
Pain
Pediatrics
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 6 – 17
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 1,010 (estimated)
- Sponsor
- Columbia University · Other
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Pain is common in children presenting to the emergency department but is frequently undertreated, leading to both short- and long-term consequences. Morphine is the standard treatment for children with moderate to severe acute pain, but its use is associated with serious side effects and caregiver and clinician concerns related to opioid administration. The investigators aim to determine if sub-di…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Age 6 to \< 18 years old
2. Chief complaint includes abdominal pain OR isolated long-bone extremity fracture (suspected or proven)
3. Self-reported pain score of ≥ 6/10
4. Requires IV morphine for analgesia as determined by the treating physician
Exclusion Criteria:
1. Weig…
Contacts